{"companyId":272623,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Gossamer Bio, Inc.","headOfficeLocation":"3115 Merryfield Row, Suite 120, San Diego, CA 92121, United States","presidentName":"Faheem Hasnain","companySummary":null,"stockCode":"GOSS","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["gossamerbio.com"],"businessContents":["Develops therapies for pulmonary hypertension and other serious diseases.","Conducts clinical-stage biopharmaceutical research and development."],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000017/goss-20251231.htm","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}